Corporate Banner
Satellite Banner
ADME Tox
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Celerion Appoints Executive Director, Applied Translational Medicine

Published: Tuesday, June 04, 2013
Last Updated: Monday, June 17, 2013
Bookmark and Share
Dr. Bruce Morimoto will have responsibility for developing and implementing strategies for patient populations in early clinical research and clinical pharmacology studies.

Celerion  announces the appointment of Dr. Bruce Morimoto as Executive Director of Applied Translational Medicine. Dr. Morimoto will also assume leadership for the External Studies Management and Clinical Monitoring Services teams.

The appointment of Dr. Morimoto reinforces Celerion’s focus on delivering Applied Translational Medicine. Celerion is focused on applying our expertise and experience to translating information gained in research discoveries, to knowledge of drug action and effect in humans to support early drug development decisions and the clinical pharmacology labeling of new medicines.

Dr. Morimoto comes to Celerion with over 20 years of experience in the pharmaceutical and biotechnology industries as well as in contract research organizations (CRO). Prior to joining Celerion, he was Vice President of Drug Development at Allon Therapeutics, where his focus was to manage their neurodegeneration and dementia therapeutic programs including preclinical, manufacturing and clinical development. Dr. Morimoto also held positions at MDS Pharma Services, a full service CRO; Neuromed Technologies, a biotech company developing novel pain therapeutics; Phoenix International Life Sciences, a global CRO; and Amur Pharmaceuticals, a biopharmaceutical company focused on diabetes and drug delivery research.

Dr. Morimoto’s hands-on drug development experience that includes program, project and portfolio management, combined with an understanding of the CRO industry, provides him with invaluable insight into how best to tackle the inclusion of patients in both clinical pharmacology as well as Phase IIa Proof-of-Concept studies.

“We are very pleased to have Bruce join the Drug Development Services team at Celerion,” said Susan Thornton Ph.D, President and CEO of Celerion. “His in-depth knowledge of drug development as well as focus on Applied Translational Medicine from both the client and CRO perspective will be a great asset to our organization.”

Dr. Morimoto earned his doctorate in biochemistry from the University of California, Los Angeles (UCLA), completed post doctorate research at University of California, Berkeley, and was also on the faculty in the Chemistry department at Purdue University.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,400+ scientific posters on ePosters
  • More than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Celerion Opens Operations in South Korea

Friday, March 07, 2014
Celerion Announces Expanded State-of-the-Art ADME Suite
The state-of-the-art ADME Suite benefits from on-site bioanalytical services and Phase I clinical facilities to offer clients a one stop solution.
Friday, May 18, 2012
Celerion Appoints Dr Raymond Farmen as Vice President of Global Bioanalytical Services
Dr Farmen will have responsibility for the company’s bioanalytical operations in Zurich, Switzerland and Lincoln, Nebraska USA.
Friday, July 08, 2011
Celerion Receives ANVISA Certification
Brazilian Regulatory Agency approves Celerion facilities in both North America and Europe to conduct clinical research and bioanalytical services.
Friday, June 24, 2011
Celerion Recognized as Member of the UK Respiratory Therapeutic Capability Cluster
Celerion will work with key decision makers and thought leaders in the UK to develop and execute Phase I and IIa studies with targeted patient populations.
Friday, April 08, 2011
Scientific News
Adoption of Three Dimensional Culture Models May Save Lives
Physiologically relevant cell models can detect chronic hepatotoxicity early in the drug discovery process.
Hope for Zika Treatment Found in Drug Screening
Johns Hopkins researchers join collaborative group to screen 6,000 existing drugs in hopes of finding treatments for Zika Virus infection.
Microbiome Impacts Tissue Repair, Regeneration
Researchers at the Stowers Institute have established a definitive link between the makeup of the microbiome, the host immune response, and an organism’s ability to heal itself.
Genome Editing Without Cleaving DNA
A team involving Kobe University researchers has succeeded in developing ‘Target-AID’, a genome editing technique that does not cleave the DNA.
Misfiring Drugs Hit the Wrong Targets
Anti-HIV protein inhibitor drugs can bind to the wrong protein, causing unwanted side effects.
Oxygen Can Impair Cancer Immunotherapy
Researchers have identified a mechanism within the lungs where anticancer immune resposnse is inhibited.
Symmetry is Key to Collagen
Researchers describe how symmetry may be the key to growing collagen fibres outside the body.
Biological Barcodes Using CRISPR
Using genome editing tools, researchers are getting closer to understand differentiation of various cell types during development.
Decades Old Chemicals Linked to Current Increased Autism Risk
The chemcials - organochlorines - were banned in the US in 1977 but their side effects are still being seen.
Gene Therapy Via Ultrasound
Research into a gene therapy approach called sonoporation could help combat heart disease and cancer.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!